MCM
TECH icon

Monimus Capital Management’s Bio-Techne TECH Stock Holding History

Monimus Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,771
Closed -$1.63M – 67
2025
Q4 		$1.63M Sell
27,771
-32,971
-54% -$2M 1.08% 36
2025
Q3 		$3.38M Buy
+60,742
New +$3.25M 2.08% 16

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Monimus Capital Management's TECH Position: Q1 2026 in Review

Monimus Capital Management sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 27,771 shares — an estimated $1.63M sold.

Monimus Capital Management first reported a position in TECH in Q3 2025 and held it in 2 quarters. The position peaked at $3.38M in Q3 2025. 583 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Monimus Capital Management reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
  • Monimus Capital Management sold 27,771 Bio-Techne shares in Q1 2026, an estimated $1.63M.
  • Monimus Capital Management first reported a position in Bio-Techne in Q3 2025 and held it in 2 quarters.
  • Monimus Capital Management's Bio-Techne position peaked at $3.38M in Q3 2025.
  • 583 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Monimus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.